Zobrazeno 1 - 10
of 442
pro vyhledávání: '"YT Tai"'
Autor:
Paul G. Richardson, Kenneth C. Anderson, YT Tai, Shohei Kikuchi, Morihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, Teru Hideshima
Publikováno v:
Leukemia
Recent studies have delineated cancer-type-specific roles of histone 3 lysine 27 (H3K27) demethylase KDM6B/JMJD3 depending on its H3K27 demethylase activity. Here we show that KDM6B is expressed in multiple myeloma (MM) cells; and that shRNA-mediated
Autor:
Joachim Wahl, Diann Blanset, YT Tai, KC Anderson, Petra Deegen, Oliver Thomas, Paul Adam, Matthias Friedrich, Susanne Hipp, Benno Rattel
Publikováno v:
Leukemia. 31:1743-1751
B-cell maturation antigen (BCMA) is a highly plasma cell-selective protein that is expressed on malignant plasma cells of multiple myeloma (MM) patients and therefore is an ideal target for T-cell redirecting therapies. We developed a bispecific T-ce
Autor:
Mehmet Kemal Samur, Nikhil C. Munshi, Jean-Bernard Lazaro, J. P. Fermand, Bertrand Arnulf, Puru Nanjappa, Alice Cleynen, Tommaso Perini, Mariateresa Fulciniti, Kenneth C. Anderson, Raphael Szalat, Hervé Avet-Loiseau, Masood A. Shammas, Michael A. Lopez, Anne S. Calkins, Kenneth Wen, Shaji Kumar, YT Tai, D Chauhan, E. Reznichenko
Publikováno v:
Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 32 (1), pp.111-119. ⟨10.1038/leu.2017.182⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 32 (1), pp.111-119. 〈10.1038/leu.2017.182〉
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 32 (1), pp.111-119. ⟨10.1038/leu.2017.182⟩
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 32 (1), pp.111-119. 〈10.1038/leu.2017.182〉
Despite the development of novel drugs, alkylating agents remain an important component of therapy in multiple myeloma (MM). DNA repair processes contribute towards sensitivity to alkylating agents and therefore we here evaluate the role of nucleotid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27af011546e111e75e88ddf05ee14554
https://hal.archives-ouvertes.fr/hal-01813384
https://hal.archives-ouvertes.fr/hal-01813384
Autor:
Mehmet Kemal Samur, D Chauhan, Jun Qi, Arghya Ray, Shijun Li, YT Tai, Nikhil C. Munshi, Ruben D. Carrasco, Deepika Sharma Das, Yan Song, KC Anderson
Publikováno v:
Oncogene. 36(40)
Proteasome inhibition is an effective therapy for multiple myeloma (MM) patients; however, the emergence of drug resistance is common. Novel therapeutic strategies to overcome proteasome inhibitor resistance are needed. In this study, we examined whe
Autor:
NC Munshi, Irene M. Ghobrial, YT Tai, Jacob P. Laubach, KC Anderson, Claudia E. Paba-Prada, Robert L. Schlossman, P. G. Richardson
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:e21-e23
Autor:
YT Tai, Mark A. Exley, Weihua Song, KC Anderson, Puru Nanjappa, Teru Hideshima, Nikhil C. Munshi, D Chauhan, Ze Tian
Publikováno v:
Leukemia
LBH589 is a novel pan-histone deacetylase (HDAC) inhibitor that has potent antitumor activity in multiple myeloma and other hematological malignancies. However, its impact on the immune system has not been defined. We here evaluated the effects of LB
Autor:
Benny Yt Tai
Publikováno v:
Asia Pacific Law Review. 17:95-114
one major worldwide development for the ombudsman office is the extension of its jurisdiction from purely one of supervision over potential maladministration to one also addressing human rights infringement. various factors determine the degree of in
Autor:
Francesca Cottini, Gullu Gorgun, YT Tai, P. G. Richardson, Diana Cirstea, Kenneth C. Anderson, Teruhiro Utsugi, Rikio Suzuki, Jiro Minami, Naoya Mimura, Teru Hideshima, Yasuhiro Yoshida, D Chauhan, Shohei Kikuchi, Jana Jakubikova, NC Munshi, Hiroto Ohguchi
Publikováno v:
Leukemia
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
Autor:
Benny Yt Tai
Publikováno v:
Public Theology in Law and Life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8260982b1b01d4982693543f057d0c6b
https://doi.org/10.2307/j.ctt163t9j5.4
https://doi.org/10.2307/j.ctt163t9j5.4
Autor:
NC Munshi, Gang An, KC Anderson, Francisco Adrian, Chirag Acharya, Z. Song, YT Tai, T. Cai, Lugui Qiu, Hua Jiang, Guang Yang, Xiaoyan Feng, L. Wang
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:e285